Answers are grounded in this paper and cite their sources.
Review highlights Quality by Design principles in pharmaceutical development, suggesting a shift to proactive quality assurance.
Quality by Design (QbD) is a strategic, risk-based approach to development and manufacturing that emphasizes building quality into a product from the very beginning, rather than testing for it after the product is finished. Historically used in the automotive and semiconductor industries, it has become the gold standard in pharmaceutical development.
No takes yet. Share an insight, caveat, or question.
Umesh* et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: